EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.102 | 3-dehydrosphinganine reductase |
skeletal muscle |
high expression |
656256 |
1.1.1.102 | 3-dehydrosphinganine reductase |
skeletal muscle |
low level of expression |
656256 |
1.1.1.103 | L-threonine 3-dehydrogenase |
skeletal muscle |
- |
655125 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
skeletal muscle |
strong mRNA expression |
692959 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
skeletal muscle |
- |
760868, 761754 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
skeletal muscle |
at baseline, mRNA levels are similar in diabetic and control sugjects for 11beta-HSD1, 11beta-HSD2, and hexose-6-phosphate dehydrogenase. 11beta-HSD1 activity is reduced in diabetic subjects, while 11beta-HSD2 activity is increased. After application of dexamethasone, 11beta-HSD1 mRNA increases in both groups, whereas 11beta-HSD2 mRNA decreases. 11beta-HSD1 activity increases in diabetic subjects, but not in controls, whereas 11beta-HSD2 activity does not change in either group; mRNA levels are similar in diabetic and control subjects for 11beta-hydroxysteroid dehydrogenase 1 and 11beta-hydroxysteroid dehydrogenase 2. 11beta-Hydroxysteroid dehydrogenase 2-activity is higher in diabetic patients. After treatment with dexamethasone, 11beta-hydroxysteroid dehydrogenase 1-mRNA increases in both groups, whereas 11beta-hydroxysteroid dehydrogenase 2-mRNA decreases. 11beta-Hydroxysteroid dehydrogenase 1-activity increases in diabetic patients, but not in control, whereas 11beta-hydroxysteroid dehydrogenase 2-activity does not change in either group |
687961 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
skeletal muscle |
isozyme 11beta-HSD1, expression analysis |
668297 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
skeletal muscle |
moderate expression rate of AKR1C23 |
669908 |
1.1.1.177 | glycerol-3-phosphate 1-dehydrogenase (NADP+) |
skeletal muscle |
highest activity |
286119 |
1.1.1.184 | carbonyl reductase (NADPH) |
skeletal muscle |
- |
697582 |
1.1.1.184 | carbonyl reductase (NADPH) |
skeletal muscle |
low expression of CBR3 |
697582 |
1.1.1.21 | aldose reductase |
skeletal muscle |
- |
286245, 738593 |
1.1.1.211 | long-chain-3-hydroxyacyl-CoA dehydrogenase |
skeletal muscle |
- |
-, 670476, 741457 |
1.1.1.23 | histidinol dehydrogenase |
skeletal muscle |
low activity |
656358 |
1.1.1.27 | L-lactate dehydrogenase |
skeletal muscle |
- |
654778, 667816, 685772, 711801, 741355 |
1.1.1.27 | L-lactate dehydrogenase |
skeletal muscle |
contains a skeletal muscle type homotetrameric enzyme, M4 |
740001 |
1.1.1.27 | L-lactate dehydrogenase |
skeletal muscle |
isoenzyme LDH-A4 |
655268 |
1.1.1.27 | L-lactate dehydrogenase |
skeletal muscle |
muscle isozyme |
686223 |
1.1.1.27 | L-lactate dehydrogenase |
skeletal muscle |
muscle-type isozyme, i.e. M4 isoform |
686014 |
1.1.1.28 | D-lactate dehydrogenase |
skeletal muscle |
- |
286491 |
1.1.1.284 | S-(hydroxymethyl)glutathione dehydrogenase |
skeletal muscle |
- |
287888 |
1.1.1.300 | NADP-retinol dehydrogenase |
skeletal muscle |
- |
656098 |
1.1.1.31 | 3-hydroxyisobutyrate dehydrogenase |
skeletal muscle |
- |
722472 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
skeletal muscle |
5% mRNA expression of Rdh5 compared to liver |
690797 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
skeletal muscle |
low activity |
692700 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
skeletal muscle |
the 3 kb isoform is the most abundant one |
692332 |
1.1.1.34 | hydroxymethylglutaryl-CoA reductase (NADPH) |
skeletal muscle |
longissimus, low expression level |
722328 |
1.1.1.345 | D-2-hydroxyacid dehydrogenase (NAD+) |
skeletal muscle |
- |
287843 |
1.1.1.35 | 3-hydroxyacyl-CoA dehydrogenase |
skeletal muscle |
- |
286592 |
1.1.1.36 | acetoacetyl-CoA reductase |
skeletal muscle |
isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.37 | malate dehydrogenase |
skeletal muscle |
- |
655141, 698113, 699253 |
1.1.1.37 | malate dehydrogenase |
skeletal muscle |
white |
656579 |
1.1.1.41 | isocitrate dehydrogenase (NAD+) |
skeletal muscle |
- |
741458 |
1.1.1.42 | isocitrate dehydrogenase (NADP+) |
skeletal muscle |
isozyme IDHP-A |
655142 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
skeletal muscle |
- |
286839 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
skeletal muscle |
low activity in female and male rats, constant at age 2 months to age 9 months |
655737 |
1.1.1.50 | 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) |
skeletal muscle |
- |
389547 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
skeletal muscle |
- |
684324 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
skeletal muscle |
- |
684324, 740849 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
skeletal muscle |
diaphragm |
287198 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
skeletal muscle |
isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.71 | alcohol dehydrogenase [NAD(P)+] |
skeletal muscle |
- |
655563 |
1.1.1.72 | glycerol dehydrogenase (NADP+) |
skeletal muscle |
- |
287283, 287286, 287287, 287288 |
1.1.1.77 | lactaldehyde reductase |
skeletal muscle |
- |
287308 |
1.1.1.78 | methylglyoxal reductase (NADH) |
skeletal muscle |
highest activity |
207968 |
1.1.1.8 | glycerol-3-phosphate dehydrogenase (NAD+) |
skeletal muscle |
- |
656777, 741302 |
1.1.1.8 | glycerol-3-phosphate dehydrogenase (NAD+) |
skeletal muscle |
about 10% of activity of adipose tissue |
657144 |
1.1.1.8 | glycerol-3-phosphate dehydrogenase (NAD+) |
skeletal muscle |
hibernator muscle, muscle isozyme |
723706 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
skeletal muscle |
at baseline, mRNA levels are similar in diabetic and control sugjects for 11beta-HSD1, 11beta-HSD2, and hexose-6-phosphate dehydrogenase. 11beta-HSD1 activity is reduced in diabetic subjects, while 11beta-HSD2 activity is increased. After application of dexamethasone, 11beta-HSD1 mRNA increases in both groups, whereas 11beta-HSD2 mRNA decreases. 11beta-HSD1 activity increases in diabetic subjects, but not in controls, whereas 11beta-HSD2 activity does not change in either group; mRNA levels are similar in diabetic and control subjects for 11beta-hydroxysteroid dehydrogenase 1 and 11beta-hydroxysteroid dehydrogenase 2. 11beta-Hydroxysteroid dehydrogenase 2-activity is higher in diabetic patients. After treatment with dexamethasone, 11beta-hydroxysteroid dehydrogenase 1-mRNA increases in both groups, whereas 11beta-hydroxysteroid dehydrogenase 2-mRNA decreases. 11beta-Hydroxysteroid dehydrogenase 1-activity increases in diabetic patients, but not in control, whereas 11beta-hydroxysteroid dehydrogenase 2-activity does not change in either group |
687961 |
1.1.5.13 | (S)-2-hydroxyglutarate dehydrogenase |
skeletal muscle |
- |
755232 |
1.1.5.3 | glycerol-3-phosphate dehydrogenase |
skeletal muscle |
- |
-, 741302 |
1.1.99.24 | hydroxyacid-oxoacid transhydrogenase |
skeletal muscle |
low enzyme activity |
664967 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
skeletal muscle |
- |
659111 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
skeletal muscle |
high expression level |
657888 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
skeletal muscle |
highest expression |
658430 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
skeletal muscle |
- |
671327 |
1.11.1.16 | versatile peroxidase |
skeletal muscle |
- |
764524 |
1.11.1.9 | glutathione peroxidase |
skeletal muscle |
- |
700167 |
1.13.11.19 | cysteamine dioxygenase |
skeletal muscle |
high activity |
687595 |
1.13.11.33 | arachidonate 15-lipoxygenase |
skeletal muscle |
- |
703235 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
skeletal muscle |
- |
713952, 728342 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
skeletal muscle |
low levels of BCO mRNA |
438228 |
1.13.11.71 | carotenoid-9',10'-cleaving dioxygenase |
skeletal muscle |
- |
720152 |
1.14.11.1 | gamma-butyrobetaine dioxygenase |
skeletal muscle |
- |
439290, 439296, 699163 |
1.14.11.16 | peptide-aspartate beta-dioxygenase |
skeletal muscle |
- |
439251 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
skeletal muscle |
- |
439243, 659235 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
skeletal muscle |
high expression of enzyme alpha-I subunit mRNA and low expression of enzyme alpha-II subunit mRNA |
439242 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
skeletal muscle |
the type I enzyme is the main enzyme form |
439243 |
1.14.11.27 | [histone H3]-dimethyl-L-lysine36 demethylase |
skeletal muscle |
- |
712996, 764642 |
1.14.11.29 | hypoxia-inducible factor-proline dioxygenase |
skeletal muscle |
expression level of of HIF-P4H-3 mRNA is highest in the adult heart, brain, placenta, lung, and skeletal muscle and in the fetal heart, spleen, and skeletal muscle |
659235 |
1.14.11.29 | hypoxia-inducible factor-proline dioxygenase |
skeletal muscle |
the levels of HIF-P4H-2 mRNA expression is highest in the adult heart, brain, lung, and liver and in the fetal brain, heart, spleen, and skeletal muscle |
659235 |
1.14.11.30 | hypoxia-inducible factor-asparagine dioxygenase |
skeletal muscle |
expresses 50fold higher levels of FIH than other tissues |
764438 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
skeletal muscle |
from leg |
657744 |
1.14.11.51 | DNA N6-methyladenine demethylase |
skeletal muscle |
N6-mA levels shows a steady increase, going along with a strong decrease of ALKBH1 during skeletal muscle development |
764640 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
skeletal muscle |
- |
754880 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
skeletal muscle |
the short isoform of JMJD2A is upregulated during muscle differentiation, expression analysis and pattern, overview |
755066 |
1.14.11.7 | procollagen-proline 3-dioxygenase |
skeletal muscle |
- |
746168 |
1.14.11.8 | trimethyllysine dioxygenase |
skeletal muscle |
musculus longissimus dorsi and musculus semimembranosus |
697027 |
1.14.13.225 | F-actin monooxygenase |
skeletal muscle |
- |
764944 |
1.14.13.39 | nitric-oxide synthase (NADPH) |
skeletal muscle |
- |
685867 |
1.14.13.8 | flavin-containing monooxygenase |
skeletal muscle |
- |
686276 |
1.14.14.18 | heme oxygenase (biliverdin-producing) |
skeletal muscle |
is slightly detectable in the abdominal skeletal muscle |
703698 |
1.14.14.94 | leukotriene-B4 20-monooxygenase |
skeletal muscle |
CYP4F11 |
660409 |
1.14.16.5 | alkylglycerol monooxygenase |
skeletal muscle |
- |
688220 |
1.14.19.1 | stearoyl-CoA 9-desaturase |
skeletal muscle |
- |
673510, 688769, 698917, 726658, 746542 |
1.14.19.1 | stearoyl-CoA 9-desaturase |
skeletal muscle |
C57Bl/B6 mice under low-fat diet have 3 to 4 times more SCD1 transcript than 129S6/SvEvTac mice under low-fat diet, mRNA increased 3fold by high-fat feeding of 129S6/SvEvTac mice and 1.5fold by high-fat feeding of C57Bl/B6 mice |
673259 |
1.14.19.1 | stearoyl-CoA 9-desaturase |
skeletal muscle |
increased relative expression level in obese insulin-resistent ZDF rats compared to lean insulin-sensitive rats |
673267 |
1.14.19.1 | stearoyl-CoA 9-desaturase |
skeletal muscle |
long-term glucose oversupply induces rapid increase in SCD expression and enzyme activity |
675626 |
1.14.19.1 | stearoyl-CoA 9-desaturase |
skeletal muscle |
low expression level of isozyme SCD1 |
688769 |
1.14.19.30 | acyl-lipid (8-3)-desaturase |
skeletal muscle |
- |
734131 |
1.14.19.44 | acyl-CoA (8-3)-desaturase |
skeletal muscle |
- |
734131 |
1.15.1.1 | superoxide dismutase |
skeletal muscle |
muscle-derived extracellular superoxide dismutase |
-, 744962 |
1.17.1.4 | xanthine dehydrogenase |
skeletal muscle |
- |
644585 |
1.17.1.4 | xanthine dehydrogenase |
skeletal muscle |
low oxidase activity |
644557, 644558 |
1.17.3.2 | xanthine oxidase |
skeletal muscle |
positive correlation between plasma xanthine oxidase activity and expression and age of the animal |
686890 |
1.2.1.104 | pyruvate dehydrogenase system |
skeletal muscle |
- |
687353, 695486, 700076, 759082 |
1.2.1.104 | pyruvate dehydrogenase system |
skeletal muscle |
overall reaction activities of the PDH and OGDH complexes are very high, in order of heart > abdominal skeletal muscle > kidney. Their gene expression is strongest in heart and skeletal muscle |
759549 |
1.2.1.105 | 2-oxoglutarate dehydrogenase system |
skeletal muscle |
- |
762766 |
1.2.1.105 | 2-oxoglutarate dehydrogenase system |
skeletal muscle |
overall reaction activities of the PDH and OGDH complexes are very high, in order of heart > abdominal skeletal muscle > kidney. Their gene expression is strongest in heart and skeletal muscle |
759549 |
1.2.1.12 | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) |
skeletal muscle |
- |
684121, 684127, 685264, 685334, 685613, 695902, 697687, 713466, 724398, 733314, 741963, 742014, 743329, 743402, 762398 |